DEXCOM INC Cash And Cash Equivalents At Carrying Value

• DEXCOM INC showed an increase of +51.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from DEXCOM INC's annual report (Form 10-K), filed with the SEC on February 12, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q4 2009: $3.58 million | Q2 2010: $6.09 million | Q3 2010: $5.53 million | Q1 2011: $3.81 million | Q2 2011: $33.89 million | Q3 2011: $17.52 million | Q1 2012: $5.10 million | Q2 2012: $6.00 million | Q3 2012: $4.70 million | Q1 2013: $18.90 million | Q2 2013: $28.20 million | Q3 2013: $33.40 million | Q1 2014: $45.70 million | Q2 2014: $49.50 million | Q3 2014: $63.20 million | Q1 2015: $54.20 million | Q2 2015: $67.70 million | Q3 2015: $85.30 million | Q1 2016: $77.90 million | Q2 2016: $87.50 million | Q3 2016: $97.70 million | Q1 2017: $153.50 million | Q2 2017: $395.90 million | Q3 2017: $402.10 million | Q1 2018: $420.40 million | Q2 2018: $300.20 million | Q3 2018: $367.40 million | Q1 2019: $1.29 billion | Q2 2019: $709.20 million | Q3 2019: $395.60 million | Q1 2020: $584.60 million | Q2 2020: $530.00 million | Q3 2020: $673.50 million | Q1 2021: $733.80 million | Q2 2021: $1.16 billion | Q3 2021: $1.44 billion | Q1 2022: $716.00 million | Q2 2022: $735.40 million | Q3 2022: $698.10 million | Q1 2023: $623.20 million | Q2 2023: $1.19 billion | Q3 2023: $643.70 million | Q1 2024: $851.20 million | Q2 2024: $939.20 million | Q3 2024: $621.20 million | Q1 2025: $904.90 million | Q2 2025: $1.16 billion | Q3 2025: $1.84 billion.
• Over the full 17 years of available data (2009 to 2025), DEXCOM INC's Cash And Cash Equivalents At Carrying Value has grown by 25,555.6%.
• Historical annual values: Fiscal year 2025: $917.70 million | Fiscal year 2024: $606.10 million | Fiscal year 2023: $566.30 million | Fiscal year 2022: $642.30 million | Fiscal year 2021: $1.05 billion | Fiscal year 2020: $817.60 million | Fiscal year 2019: $446.20 million | Fiscal year 2018: $1.14 billion | Fiscal year 2017: $441.50 million | Fiscal year 2016: $94.50 million | Fiscal year 2015: $86.10 million | Fiscal year 2014: $71.80 million | Fiscal year 2013: $43.20 million | Fiscal year 2012: $8.10 million | Fiscal year 2011: $2.60 million | Fiscal year 2010: $4.90 million | Fiscal year 2009: $3.58 million.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026